Author

Lisa Squassante

Observed names: L Squassante, L. Squassante, Lisa Squassante,, Squassante, L, Squassante, Lisa

Observed institutions: F. Hoffmann-La Roche AG, University of Verona, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States), GlaxoSmithKline (Italy), Ospedaliera di Piacenza

OpenAlex ID: A5008773192

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.

1996 · S Rossi, M Di Stasi, et al. · American Journal of Roentgenology · 759

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder

2019 · Federico Bolognani, Marta del Valle Rubido, et al. · Science Translational Medicine · 128

Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study

2008 · James M. Stone, Kjell Erlandsson, et al. · Psychopharmacology · 103

Absolute Quantification of Cerebral Blood Flow with Magnetic Resonance, Reproducibility of the Method, and Comparison with H 2 15 O Positron Emission Tomography

2002 · Timothy J. Carroll, Vincenzo Teneggi, et al. · Journal of Cerebral Blood Flow & Metabolism · 102

PDF

Assessment of Cognitive Scales to Examine Memory, Executive Function and Language in Individuals with Down Syndrome: Implications of a 6-month Observational Study

2015 · Xavier Liogier d'Ardhuy, Jamie O. Edgin, et al. · Frontiers in Behavioral Neuroscience · 94

PDF

Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia

2012 · Paolo Bettica, Lisa Squassante, et al. · Neuropsychopharmacology · 92

The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia

2012 · Paolo Bettica, Lisa Squassante, et al. · SLEEP · 86

Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal

2002 · Vincenzo Teneggi, Stephen Tiffany, et al. · Psychopharmacology · 81

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

2016 · Daniel Umbricht, Marta del Valle Rubido, et al. · Neuropsychopharmacology · 80

PDF

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

2011 · Emiliangelo Ratti, Kevin Bellew, et al. · Journal of Clinical Psychopharmacology · 64

Incidence of gallstones in a population of patients with cirrhosis

1994 · Fabio Fornari, Davide Imberti, et al. · Journal of Hepatology · 63

Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist

2011 · Paolo Bettica, Gianluca Nucci, et al. · Journal of Psychopharmacology · 59

Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia

2013 · Emiliangelo Ratti, David J. Carpenter, et al. · SLEEP · 51

PDF

Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects

2005 · Stefano Zanone Poma, Stefano Milleri, et al. · Journal of Psychopharmacology · 49

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome

2022 · Celia Goeldner, Priya S. Kishnani, et al. · Journal of Neurodevelopmental Disorders · 48

PDF

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease

1998 · Gabriele Di Lorenzo, Giuseppina Morici, et al. · Clinical Therapeutics · 48

Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder

2022 · Eric Hollander, Suma Jacob, et al. · JAMA Psychiatry · 47

PDF

Salmeterol and fluticasone propionate given as a combination

2001 · S. Kirby, C. Falcoz, et al. · European Journal of Clinical Pharmacology · 44

Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal‐induced craving

2002 · Vincenzo Teneggi, Lisa Squassante, et al. · British Journal of Clinical Pharmacology · 42

PDF

Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man

2021 · Joerg F. Hipp, Frederic Knoflach, et al. · Scientific Reports · 40

PDF

Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h

2005 · Vincenzo Teneggi, Stephen T. Tiffany, et al. · Psychopharmacology · 39

Hepatocellular Carcinoma in Liver Cirrhosis: A Prospective Study

1993 · D. Imberti, F. Fornari, et al. · Scandinavian Journal of Gastroenterology · 39

Ketamine displaces the novel NMDA receptor SPET probe [123I]CNS-1261 in humans in vivo

2006 · James M. Stone, Kjell Erlandsson, et al. · Nuclear Medicine and Biology · 34

Troglitazone has no effect on red cell mass or other erythropoietic parameters

1999 · M. M. R. Young, L. Squassante, et al. · European Journal of Clinical Pharmacology · 33

Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs

2000 · R. Kunka, S. Andrews, et al. · Respiratory Medicine · 32

Works count: 83

Citation count: 2,558

H-index: 26

I10-index: 38